Recruiting

The Effect of Interventions for Health Behaviors in Hypertensive Patients

ClinicalTrials.gov IDNCT06640751

PhaseNA

Enrollment240

SponsorNanjing Medical University

Age18 Years – 80 Years

SexALL

I'm interested View official listing

Conditions studied

Hypertension, Health Behavior, Public Health

About this study

Hypertension is a major risk factor for cardiovascular disease, chronic kidney disease, and premature death worldwide. With an aging population and changes in dietary patterns and lifestyles, the prevalence of hypertension is rising globally, especially in developing countries. Hypertension is the most common chronic disease and a growing public health problem in China. A recent study estimated the prevalence of hypertension to be 28.56 % ± 10.44 %, ranging from 14.28% to 44.28% among the Chinese population aged over 15 years. The PRECEED-PROCEDE model provides a framework to help health planners and policymakers design effective health interventions based on evaluation and analysis of situations. This model has been used in different recent studies related to behavioral change. The study aims to examine the effectiveness of interventions for health behaviors in hypertensive patients based on the PRECEDE-PROCEED model.

Interventions

Behavioral: Health behavior intervention — The program is a group-based intervention provided by a healthcare team consisting of researchers, cardiologists, family doctors, community healthcare workers, psychologists, and health education specialists. The intervention is structured around three modules-predisposing, enabling, and reinforcing factors-that provide a framework for educational interventions aimed at promoting healthy behaviors in hypertensive patients.

Primary outcomes

Health behavior (1. Before the intervention: Baseline 2. During the intervention (at the end of the 3th, 6th month of the study) 3. the follow-up test (posttests - at the end of the 9th month of the study))
systolic blood pressure (1. Before the intervention: Baseline 2. During the intervention (at the end of the 3th, 6th month of the study) 3. the follow-up test (posttests - at the end of the 9th month of the study))
Delay discounting (1. Before the intervention: Baseline 2. During the intervention (at the end of the 3th, 6th month of the study) 3. the follow-up test (posttests - at the end of the 9th month of the study))

Eligibility information

Inclusion Criteria: 1. Patients diagnosed with mild to moderate primary hypertension according to the diagnostic criteria of the "2018 Revised Edition of the Chinese Guidelines for the Prevention and Treatment of Hypertension," whose blood pressure is not well controlled or who have poor treatment compliance; 2. Age greater than 18 years and less than 80 years; 3. Normal language communication ability and willingness to participate in the study; 4. Have lived in the community for at least 12 months. Exclusion Criteria: 1. Patients who lack basic behavioral abilities, have impaired memory function, or have limited language expression abilities; 2. Patients who are simultaneously participating in other intervention studies.

Study locations

Community health service center, Nanjing, Jiangsu China

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-05.